# Brain Operational Verification Report (2026)

## Mission and evidence scope

This report records the bounded operational end-to-end verification triggered from issue #146. It does **not** establish that every Brain capability is production-ready or that Brain can operate as a dependable general-purpose desktop agent.

- **Issue:** [#146](https://github.com/madnessgate44-debug/brain/issues/146)
- **Company workflow:** [Run #38110807822](https://github.com/madnessgate44-debug/brain/actions/runs/38110807822)
- **Base commit:** `c2a6d1e83d41233300b835b8adc1a8fbe8097e60`
- **PR:** [#175](https://github.com/madnessgate44-debug/brain/pull/175)
- **PR branch:** `brain/mission-e9914a758dd3`
- **PR head verified:** `ac9f97bfc3acaad95d3e28572f25c17a44ed0f5b`
- **Changed files:** `docs/BRAIN_OPERATIONAL_VERIFICATION_2026.md`, `tests/test_mission_capabilities.py`

## Acceptance criteria

### R1 — Intake and classification: PASS

Issue #146 triggered company workflow run #38110807822. The workflow completed successfully and published its execution report to the issue. The mission was classified as a bounded repository-change task.

### R2 — Base commit and scope: PASS

The base SHA and changed-file list are recorded above. The PR contains one verification document and one regression-test file. No merge or deployment was performed.

### R3 — Specialist orchestration evidence: PARTIAL

The run report records these role statuses: product owner PASS, UX designer PASS, architect PASS, developer APPLIED, code reviewer PASS, QA engineer PASS, security auditor PASS, customer advocate PASS, and release manager PASS.

**Limitation:** The status labels and generated role outputs are not equivalent to independent proof that every role performed a substantive, independent review. The PR has no submitted GitHub review; the review API returned an empty list. Treat independent human review as still required.

### R4 — CI, repository tests, and browser smoke: PASS, with a test-skip note

All three post-PR workflows completed successfully against the same PR head SHA `ac9f97bfc3acaad95d3e28572f25c17a44ed0f5b`:

- [Python CI — run #38110913256](https://github.com/madnessgate44-debug/brain/actions/runs/38110913256): PASS; pytest reported **238 passed, 1 skipped**.
- [Repository test suite — run #38110914312](https://github.com/madnessgate44-debug/brain/actions/runs/38110914312): PASS; pytest reported **238 passed, 1 skipped**.
- [Browser runtime smoke — run #38110915303](https://github.com/madnessgate44-debug/brain/actions/runs/38110915303): PASS; the dedicated `tests/test_browser_live_smoke.py` invocation reported **1 passed** after installing Playwright Chromium.
- [Remote test runner — run #38110855641](https://github.com/madnessgate44-debug/brain/actions/runs/38110855641): PASS; pytest reported **238 passed, 1 skipped**.

The general pytest suites skip the live browser smoke test; the separate browser workflow ran that test successfully. These results apply to the PR head SHA above, not to a merged `main` branch.

### R5 — Failure recovery under an injected fault: NOT TESTED

No isolated, reversible fault-injection run was demonstrated in this mission. Existing unit tests cover failure-reporting and recovery code, but they do not substitute for a recorded end-to-end injected-failure exercise. This criterion remains open.

### R6 — Isolated PR, no merge/deploy: PASS

PR #175 remains open and unmerged. No deployment was performed as part of this mission.

### R7 — Outcome report: PASS

The report distinguishes passed checks from untested failure injection and the limits of specialist evidence.

## Final verdict

- **PASS:** Intake/classification; base SHA and scope recording; successful CI, repository tests, and dedicated browser smoke; isolated PR; no merge/deploy.
- **PARTIAL:** Specialist-stage evidence. Role statuses exist, but they do not prove independent substantive review.
- **NOT TESTED:** End-to-end injected failure and recovery.
- **Overall:** **Operational workflow run succeeded, but full acceptance is not yet established.** Human review of PR #175 and a safe, isolated failure-injection test remain outstanding.